Search
2026
2025
2024
2023
-
May 28, 2025
YolTech Therapeutics Appoints Dr. Alexandre Moreau to Lead Global Business DevelopmentRead More
-
May 21, 2025
YolTech Therapeutics to Present Positive Clinical Data of YOLT-203 for the Treatment of PH1 at the ERA Congress 2025Read More
-
Apr 28, 2025
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial HypercholesterolemiaRead More
-
Apr 24, 2025
YolTech Therapeutics to Present Positive Clinical Data of YOLT-101 for the Treatment of HeFH at the EAS Congress 2025Read More
-
Apr 10, 2025
YolTech Receives U.S. FDA ODD for YOLT-202 in Treating AATDRead More
